BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29663354)

  • 21. Treatment for Livedoid Vasculopathy: A Systematic Review.
    Micieli R; Alavi A
    JAMA Dermatol; 2018 Feb; 154(2):193-202. PubMed ID: 29141075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adalimumab in the Treatment of Recalcitrant Livedoid Vasculopathy.
    Bhatt DM; Bhamburkar S; Madke B; Jangid SD; Khan A
    Cureus; 2023 Dec; 15(12):e50053. PubMed ID: 38186477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrophie blanche: is it associated with venous disease or livedoid vasculopathy?
    Alavi A; Hafner J; Dutz JP; Mayer D; Sibbald RG; Criado PR; Senet P; Callen JP; Phillips TJ; Romanelli M; Kirsner RS
    Adv Skin Wound Care; 2014 Nov; 27(11):518-24; quiz 525-6. PubMed ID: 25325229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Livedoid vasculopathy associated with sickle cell trait: significant improvement on aspirin treatment.
    El Khoury J; Taher A; Kurban M; Kibbi AG; Abbas O
    Int Wound J; 2012 Jun; 9(3):344-7. PubMed ID: 22044499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs).
    Hakeam HA; Al-Sanea N
    J Thromb Thrombolysis; 2017 Apr; 43(3):343-351. PubMed ID: 28050755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale.
    Drabik A; Hillgruber C; Goerge T
    JMIR Res Protoc; 2014 Dec; 3(4):e73. PubMed ID: 25500152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of livedoid vasculopathy to rivaroxaban.
    Winchester DS; Drage LA; Davis MD
    Br J Dermatol; 2015 Apr; 172(4):1148-50. PubMed ID: 25255997
    [No Abstract]   [Full Text] [Related]  

  • 30. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
    Adachi T; Hoshino H; Takagi M; Fujioka S;
    Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol.
    Criado PR; de Souza EspinelI DP; Valentef NS; Alavi A; Kirsner RS
    Dermatol Ther; 2015; 28(4):248-53. PubMed ID: 25824252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case series of recalcitrant livedoid vasculopathy treated with rivaroxaban.
    Lee JM; Kim IH
    Clin Exp Dermatol; 2016 Jul; 41(5):559-61. PubMed ID: 26993107
    [No Abstract]   [Full Text] [Related]  

  • 34. A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy.
    Seguí M; Llamas-Velasco M
    Front Med (Lausanne); 2022; 9():993515. PubMed ID: 36569162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tonsillectomy on rivaroxaban.
    Saini AT; Schorn VJ; Lin FY
    Am J Otolaryngol; 2015; 36(2):280-2. PubMed ID: 25456169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.
    Gardette E; Moguelet P; Bouaziz JD; Lipsker D; Dereure O; Le Pelletier F; Lok C; Maisonobe T; Bessis D; Conard J; Francès C; Barete S
    Acta Derm Venereol; 2018 Oct; 98(9):842-847. PubMed ID: 29738044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Livedoid vasculopathy - A diagnostic and therapeutic challenge.
    Burg MR; Mitschang C; Goerge T; Schneider SW
    Front Med (Lausanne); 2022; 9():1012178. PubMed ID: 36262273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review.
    Kim EJ; Yoon SY; Park HS; Yoon HS; Cho S
    Dermatol Ther; 2015; 28(5):287-90. PubMed ID: 25845419
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.